GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 701 filers reported holding GLAXOSMITHKLINE PLC in Q3 2014. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $496,000 | 0.0% | 11,389 | 0.0% | 0.02% | +15.0% |
| Q1 2022 | $496,000 | -6.1% | 11,389 | -4.9% | 0.02% | 0.0% |
| Q4 2021 | $528,000 | +3.3% | 11,980 | -10.4% | 0.02% | -4.8% |
| Q3 2021 | $511,000 | +131.2% | 13,374 | +141.0% | 0.02% | +110.0% |
| Q2 2021 | $221,000 | +8.3% | 5,550 | +25.3% | 0.01% | -66.7% |
| Q3 2014 | $204,000 | -9.7% | 4,431 | +5.0% | 0.03% | -6.2% |
| Q2 2014 | $226,000 | +0.4% | 4,220 | 0.0% | 0.03% | -5.9% |
| Q1 2014 | $225,000 | 0.0% | 4,220 | 0.0% | 0.03% | 0.0% |
| Q4 2013 | $225,000 | – | 4,220 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $17,248,000 | 7.33% |
| KAHN BROTHERS GROUP INC | 1,055,085 | $45,495,265,000 | 6.94% |
| NEXTHERA CAPITAL LP | 322,000 | $13,885,000 | 6.05% |
| EQUITY INVESTMENT CORP | 2,494,668 | $107,570,000 | 3.68% |
| Bruderman Asset Management, LLC | 310,248 | $13,378,000 | 3.57% |
| Keystone Financial Planning, Inc. | 131,006 | $5,649,000 | 3.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 450,000 | $19,404,000 | 3.30% |
| Hamlin Capital Management, LLC | 1,765,115 | $76,112,000 | 3.18% |
| Holloway Wealth Management, LLC | 116,899 | $5,041,000 | 3.16% |
| P.R. Herzig & Co. Inc. | 37,650 | $1,623,000 | 3.14% |